Research and Markets (http://www.researchandmarkets.com/research/2svcxv/respiratory_tract) has announced the addition of the "Respiratory Tract Infections-Pipeline Insights, 2015" subscription to their offering.

This Respiratory Tract Infections Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Respiratory Tract Infections.

This report provides information on the therapeutic development based on the Respiratory Tract Infections dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Respiratory Tract Infections Overview
  2. Respiratory Tract Infections Pipeline Therapeutics
  3. Respiratory Tract Infections Therapeutics under Development by Companies
  4. Respiratory Tract Infections Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Respiratory Tract Infections Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Respiratory Tract Infections Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Respiratory Tract Infections Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Respiratory Tract Infections - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Respiratory Tract Infections - Discontinued Products
  19. Respiratory Tract Infections - Dormant Products
  20. Companies Involved in Therapeutics Development for Respiratory Tract Infections
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/2svcxv/respiratory_tract